Sm. Lynch et al., FORMATION OF NON-CYCLOOXYGENASE-DERIVED PROSTANOIDS (F-2-ISOPROSTANES) IN PLASMA AND LOW-DENSITY-LIPOPROTEIN EXPOSED TO OXIDATIVE STRESS IN-VITRO, The Journal of clinical investigation, 93(3), 1994, pp. 998-1004
F-2-isoprostanes are prostaglandin F-2-like compounds that are known t
o be formed in vivo by free radical oxidation of arachidonyl-containin
g lipids, and their plasma levels have been suggested as indicators of
in vivo oxidative stress. As oxidation of LDL, a likely causal factor
in atherosclerosis, involves lipid peroxidation, we investigated whet
her F-2-isoprostanes are formed in plasma and LDL exposed to oxidative
stress, and how F-2-isoprostane formation is related to endogenous an
tioxidant status. In plasma exposed to aqueous peroxyl radicals, lipid
hydroperoxides and esterified F-2-isoprostanes were formed simultaneo
usly after endogenous ascorbate and ubiquinol-10 had been exhausted, d
espite the continued presence of urate, alpha-tocopherol, beta-caroten
e, and lycopene. In isolated LDL exposed to aqueous peroxyl radicals o
r Cu2+, consumption of endogenous ubiquinol-10 and alpha-tocopherol wa
s followed by rapid formation and subsequent breakdown of lipid hydrop
eroxides and esterified F-2-isoprostanes, and a continuous increase in
LDL's electronegativity, indicative of atherogenic modification. In C
u2+-exposed LDL, the decrease in esterified F-2-isoprostane levels was
paralleled by the appearance of free F-2-isoprostanes, suggesting tha
t hydrolysis by an LDL-associated activity had occurred. Our data sugg
est that F-2-isoprostanes are useful markers of LDL oxidation in vivo.
As F-2-isoprostanes are potent vasoconstrictors and can modulate plat
elet aggregation, their formation in LDL demonstrated here may also ha
ve important implications for the etiology of cardiovascular disease.